PELL BIO-MED TECHNOLOGY CO LTDPELL BIO-MED TECHNOLOGY CO LTDPELL BIO-MED TECHNOLOGY CO LTD

PELL BIO-MED TECHNOLOGY CO LTD

No trades
See on Supercharts
Market capitalization
‪4.66 B‬TWD
‪−398.76 M‬TWD
‪18.03 M‬TWD
‪28.27 M‬
Beta (1Y)
0.35
Employees (FY)
94
Revenue / Employee (1Y)
‪191.84 K‬TWD
Net income / Employee (1Y)
‪−4.24 M‬TWD

About PELL BIO-MED TECHNOLOGY CO LTD


CEO
Cheng Lung Lin
Headquarters
Taipei
Founded
2017
ISIN
TW0006949001
FIGI
BBG01LTL8817
Pell Bio-Med Technology Co., Ltd. operates as a biotechnology company. It provides cell culture technology development, clinical application of cell therapy and other services. The company was founded on March 30, 2017 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6949 is 80.6 TWD — it has decreased by −3.47% in the past 24 hours. Watch PELL BIO-MED TECHNOLOGY CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange PELL BIO-MED TECHNOLOGY CO LTD stocks are traded under the ticker 6949.
6949 stock has fallen by −4.62% compared to the previous week, the month change is a −10.24% fall, over the last year PELL BIO-MED TECHNOLOGY CO LTD has showed a −23.96% decrease.
6949 reached its all-time high on May 3, 2024 with the price of 178.5 TWD, and its all-time low was 70.6 TWD and was reached on Mar 21, 2024. View more price dynamics on 6949 chart.
See other stocks reaching their highest and lowest prices.
6949 stock is 3.73% volatile and has beta coefficient of 0.35. Track PELL BIO-MED TECHNOLOGY CO LTD stock price on the chart and check out the list of the most volatile stocks — is PELL BIO-MED TECHNOLOGY CO LTD there?
Yes, you can track PELL BIO-MED TECHNOLOGY CO LTD financials in yearly and quarterly reports right on TradingView.
6949 net income for the last quarter is ‪−100.84 M‬ TWD, while the quarter before that showed ‪−101.55 M‬ TWD of net income which accounts for 0.70% change. Track more PELL BIO-MED TECHNOLOGY CO LTD financial stats to get the full picture.
No, 6949 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 94.00 employees. See our rating of the largest employees — is PELL BIO-MED TECHNOLOGY CO LTD on this list?
Like other stocks, 6949 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PELL BIO-MED TECHNOLOGY CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PELL BIO-MED TECHNOLOGY CO LTD technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PELL BIO-MED TECHNOLOGY CO LTD stock shows the strong sell signal. See more of PELL BIO-MED TECHNOLOGY CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.